Latest Commercial Rollout News

Aguia Resources has successfully commissioned its Caçapava do Sul plant, raising Pampafós phosphate fertilizer capacity to over 200,000 tonnes per annum and launching commercial sales in Southern Brazil.

Swift TV Ltd has secured $2.33 million through a $1.9 million placement and a $430,000 debt conversion, boosting its capacity to deliver contracted deployments and expand recurring revenue streams.

Yojee Limited has secured Wayfinder Cargo Solutions as its second commercial customer for the MOSAIC freight forwarding platform, marking full operational coverage across all freight modes and directions ahead of its full commercial launch.

Optiscan Imaging has reached the halfway recruitment milestone in its first in-human breast cancer study, advancing its regulatory and commercial ambitions with promising clinical data and expanded trial sites.

Swift TV has completed a multi-year Google certification process for its enterprise connected TV platform, validating its technology and supporting ongoing deployments across mining, aged care, and hospitality sectors.

ReNerve has inked an exclusive three-year deal with Hong Kong’s Swedish Trading Company to distribute its nerve repair products across a vast and dynamic healthcare region.

4DMedical has landed a three-year commercial contract with SimonMed Imaging, deploying its CT:VQ™ technology across more than 170 US outpatient centres, marking a significant step in its US market expansion.

OncoSil Medical has secured a pivotal ethics committee approval in Italy, reclassifying its OSPRItaly registry and enabling a streamlined procurement process that could double the number of authorised hospitals using its OncoSil™ device by mid-2027.

Thrive Tribe Technologies (ASX:1TT) is fast-tracking the relaunch of its legacy HR platforms, WooBoard and REFFIND, integrating AI features to serve enterprise, government, and defense sectors managing dispersed workforces.

Memphasys has landed a major 1,000-cartridge order for its Felix™ System from MENA distributor ITL, with strong repeat demand from Qatar’s Hamad Medical Corporation and new market expansions into UAE, Kuwait, and soon Turkey.

Osteopore has secured Hainan FDA approval to clinically use and sell its custom orthopaedic devices at Shanghai Ruijin Hospital’s Hainan branch, marking a key step towards wider China market access. The company has scheduled its first patient surgery for June 2026.

Cleo Diagnostics has laid out a clear U.S. reimbursement pathway for its ovarian cancer test, leveraging an existing CPT code to enable early market entry and data collection ahead of FDA clearance.